These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 14618553

  • 21. Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia.
    Möller HJ, Riedel M, Jäger M, Wickelmaier F, Maier W, Kühn KU, Buchkremer G, Heuser I, Klosterkötter J, Gastpar M, Braus DF, Schlösser R, Schneider F, Ohmann C, Riesbeck M, Gaebel W.
    Int J Neuropsychopharmacol; 2008 Nov; 11(7):985-97. PubMed ID: 18466670
    [Abstract] [Full Text] [Related]

  • 22. A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia.
    Lindenmayer JP, Khan A, Iskander A, Abad MT, Parker B.
    J Clin Psychiatry; 2007 Mar; 68(3):368-79. PubMed ID: 17388705
    [Abstract] [Full Text] [Related]

  • 23. [Incidence of extrapyramidal symptoms during treatment with olanzapine, haloperidol and risperidone: results of an observational study].
    Sacristán JA, Gómez JC, Ferre F, Gascón J, Pérez Bravo A, Olivares JM.
    Actas Esp Psiquiatr; 2001 Mar; 29(1):25-32. PubMed ID: 11333516
    [Abstract] [Full Text] [Related]

  • 24. Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study.
    Lindenmayer JP, Czobor P, Volavka J, Lieberman JA, Citrome L, Sheitman B, Chakos M, McEvoy JP.
    J Clin Psychiatry; 2002 Oct; 63(10):931-5. PubMed ID: 12416603
    [Abstract] [Full Text] [Related]

  • 25. A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial.
    Sikich L, Hamer RM, Bashford RA, Sheitman BB, Lieberman JA.
    Neuropsychopharmacology; 2004 Jan; 29(1):133-45. PubMed ID: 14583740
    [Abstract] [Full Text] [Related]

  • 26. The relationship between negative symptoms of schizophrenia and extrapyramidal side effects with haloperidol and olanzapine.
    Allan ER, Sison CE, Alpert M, Connolly B, Crichton J.
    Psychopharmacol Bull; 1998 Jan; 34(1):71-4. PubMed ID: 9564201
    [Abstract] [Full Text] [Related]

  • 27. Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study.
    de Haan L, van Bruggen M, Lavalaye J, Booij J, Dingemans PM, Linszen D.
    Am J Psychiatry; 2003 Feb; 160(2):303-9. PubMed ID: 12562577
    [Abstract] [Full Text] [Related]

  • 28. Olanzapine: an updated review of its use in the management of schizophrenia.
    Bhana N, Foster RH, Olney R, Plosker GL.
    Drugs; 2001 Feb; 61(1):111-61. PubMed ID: 11217867
    [Abstract] [Full Text] [Related]

  • 29. Intramuscular olanzapine and intramuscular haloperidol in acute schizophrenia: antipsychotic efficacy and extrapyramidal safety during the first 24 hours of treatment.
    Wright P, Lindborg SR, Birkett M, Meehan K, Jones B, Alaka K, Ferchland-Howe I, Pickard A, Taylor CC, Roth J, Battaglia J, Bitter I, Chouinard G, Morris PL, Breier A.
    Can J Psychiatry; 2003 Dec; 48(11):716-21. PubMed ID: 14733451
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
    Citrome L, Meng X, Hochfeld M, Stahl SM.
    Hum Psychopharmacol; 2012 Jan; 27(1):24-32. PubMed ID: 22161738
    [Abstract] [Full Text] [Related]

  • 32. Sex differences in clinical response to olanzapine compared with haloperidol.
    Goldstein JM, Cohen LS, Horton NJ, Lee H, Andersen S, Tohen M, Crawford A, Tollefson G.
    Psychiatry Res; 2002 May 15; 110(1):27-37. PubMed ID: 12007591
    [Abstract] [Full Text] [Related]

  • 33. Olanzapine vs. haloperidol in the treatment of elderly chronic schizophrenia patients.
    Barak Y, Shamir E, Zemishlani H, Mirecki I, Toren P, Weizman R.
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct 15; 26(6):1199-202. PubMed ID: 12452546
    [Abstract] [Full Text] [Related]

  • 34. Depressive signs and symptoms in schizophrenia: a prospective blinded trial of olanzapine and haloperidol.
    Tollefson GD, Sanger TM, Lu Y, Thieme ME.
    Arch Gen Psychiatry; 1998 Mar 15; 55(3):250-8. PubMed ID: 9510219
    [Abstract] [Full Text] [Related]

  • 35. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
    Volavka J, Czobor P, Sheitman B, Lindenmayer JP, Citrome L, McEvoy JP, Cooper TB, Chakos M, Lieberman JA.
    Am J Psychiatry; 2002 Feb 15; 159(2):255-62. PubMed ID: 11823268
    [Abstract] [Full Text] [Related]

  • 36. Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia.
    Kinon BJ, Basson BR, Gilmore JA, Tollefson GD.
    J Clin Psychiatry; 2001 Feb 15; 62(2):92-100. PubMed ID: 11247108
    [Abstract] [Full Text] [Related]

  • 37. Actigraphic measurement of the effects of single-dose haloperidol and olanzapine on spontaneous motor activity in normal subjects.
    Kiang M, Daskalakis ZJ, Christensen BK, Remington G, Kapur S.
    J Psychiatry Neurosci; 2003 Jul 15; 28(4):293-9. PubMed ID: 12921224
    [Abstract] [Full Text] [Related]

  • 38. Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial.
    Beasley CM, Hamilton SH, Crawford AM, Dellva MA, Tollefson GD, Tran PV, Blin O, Beuzen JN.
    Eur Neuropsychopharmacol; 1997 May 15; 7(2):125-37. PubMed ID: 9169300
    [Abstract] [Full Text] [Related]

  • 39. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol.
    Tollefson GD, Beasley CM, Tamura RN, Tran PV, Potvin JH.
    Am J Psychiatry; 1997 Sep 15; 154(9):1248-54. PubMed ID: 9286184
    [Abstract] [Full Text] [Related]

  • 40. The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia.
    David SR, Taylor CC, Kinon BJ, Breier A.
    Clin Ther; 2000 Sep 15; 22(9):1085-96. PubMed ID: 11048906
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.